{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:40:07Z","timestamp":1749580807430,"version":"3.41.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00228-025-03840-8","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T20:19:04Z","timestamp":1745439544000},"page":"1043-1054","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Signals from randomized clinical trials predicting hepatotoxicity of flupirtine: systematic review"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6854-6702","authenticated-orcid":false,"given":"Mahir","family":"Fidahic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-4103","authenticated-orcid":false,"given":"Emilija","family":"Lozo Vukovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8882-9769","authenticated-orcid":false,"given":"Ewa","family":"Balkowiec-Iskra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7713-3628","authenticated-orcid":false,"given":"Darko","family":"Krnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5295-1252","authenticated-orcid":false,"given":"Adriana","family":"Andric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-0748","authenticated-orcid":false,"given":"Zeljana","family":"Margan Koletic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8467-6061","authenticated-orcid":false,"given":"Livia","family":"Puljak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"3840_CR1","doi-asserted-by":"crossref","unstructured":"Anderson N, Borlak J (2011) Correlation versus causation? Pharmacovigilance of the analgesic flupirtine exemplifies the need for refined spontaneous ADR reporting. PLoS ONE 6(10):e25221","DOI":"10.1371\/journal.pone.0025221"},{"key":"3840_CR2","unstructured":"Arzneimittelkommission der Deutschen Arzteschaft. Leberschaden unter Flupirtin (Aus der UAW-Datenbank) (2007). Dtsch Arztebl\u00a0 104(46):A 3200"},{"key":"3840_CR3","unstructured":"European medicines agency (2013) Flupirtine-containing medicines - referral. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/flupirtine-containing-medicines. Accessed 19 Apr 2025"},{"key":"3840_CR4","unstructured":"European Medicines Agency (2013) Meeting highlights from the pharmacovigilance risk assessment committee (PRAC) 10-13 June 2013. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/flupirtine-containing-medicines. Accessed 19 Apr 2025"},{"key":"3840_CR5","unstructured":"European Medicines Agency: PRAC recommends restricting the use of flupirtinecontaining medicines (2013). Available at: https:\/\/www.europeansources.info\/record\/prac-recommendsrestricting-the-use-of-flupirtine-containing-medicines\/. Accessed 19 Apr 2025"},{"issue":"4","key":"3840_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00228-013-1631-4","volume":"70","author":"A Douros","year":"2014","unstructured":"Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Orzechowski HD, Kreutz R, Garbe E (2014) Flupirtine-induced liver injury\u2013seven cases from the Berlin case-control surveillance study and review of the German spontaneous adverse drug reaction reporting database. Eur J Clin Pharmacol 70(4):453\u2013459","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3840_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00228-015-1810-6","volume":"71","author":"A Douros","year":"2015","unstructured":"Douros A, Bronder E, Andersohn F, Klimpel A, Thomae M, Orzechowski HD, Kreutz R, Garbe E (2015) Erratum to: Flupirtine-induced liver injury\u2013seven cases from the Berlin case-control surveillance study and review of the German spontaneous adverse drug reaction reporting database. Eur J Clin Pharmacol 71(3):387","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"3840_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/FPC.0000000000000209","volume":"26","author":"P Nicoletti","year":"2016","unstructured":"Nicoletti P, Werk AN, Sawle A, Shen Y, Urban TJ, Coulthard SA, Bjornsson ES, Cascorbi I, Floratos A, Stammschulte T et al (2016) HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury. Pharmacogenet Genomics 26(5):218\u2013224","journal-title":"Pharmacogenet Genomics"},{"key":"3840_CR9","unstructured":"European Medicines Agency (2018) Flupirtine-containing medicinal products - referral. London. Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/flupirtine-containingmedicinal-products. Accessed 19 Apr 2025"},{"issue":"1","key":"3840_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1213\/ANE.0000000000003355","volume":"127","author":"L Puljak","year":"2018","unstructured":"Puljak L (2018) Flupirtine, an effective analgesic, but hepatotoxicity should limit its use. Anesth Analg 127(1):309\u2013310","journal-title":"Anesth Analg"},{"key":"3840_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/JPR.S154447","volume":"11","author":"L Puljak","year":"2018","unstructured":"Puljak L (2018) Randomized controlled trial about pain medication flupirtine ignores recent pharmacovigilance warnings. J Pain Res 11:177\u2013180","journal-title":"J Pain Res"},{"issue":"1","key":"3840_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/03007995.2018.1528217","volume":"35","author":"L Puljak","year":"2019","unstructured":"Puljak L (2019) Prescribers\u2019 compliance is part of benefit-risk assessment of medicines and it can lead to failure of risk minimization measures and withdrawals of medicines. Curr Med Res Opin 35(1):5\u20136","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"3840_CR13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","volume":"74","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed) 74(9):790\u2013799","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"3840_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"issue":"7","key":"3840_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4103\/0019-5049.160937","volume":"59","author":"V Ahuja","year":"2015","unstructured":"Ahuja V, Mitra S, Kazal S, Huria A (2015) Comparison of analgesic efficacy of flupirtine maleate and ibuprofen in gynaecological ambulatory surgeries: a randomized controlled trial. Indian J Anaesth 59(7):411\u2013415","journal-title":"Indian J Anaesth"},{"issue":"1","key":"3840_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/0259-1162.150681","volume":"9","author":"JP Attri","year":"2015","unstructured":"Attri JP, Sandhu GK, Khichy S, Singh H, Singh K, Sharan R (2015) Comparative evaluation of oral flupirtine and oral diclofenac sodium for analgesia and adverse effects in elective abdominal surgeries. Anesth Essays Res 9(1):72\u201378","journal-title":"Anesth Essays Res"},{"key":"3840_CR17","doi-asserted-by":"crossref","unstructured":"Banerjee M, Bhattacharyya K, Rathindra NS, Balaram G (2012): Comparative study of efficacy and tolerability of flupirtine versus tramadol in non-steroidal anti-inflammatory drug intolerant mechanical low back pain.\u00a0Indian J Rheum 7(3):135\u2013140","DOI":"10.1016\/j.injr.2012.06.002"},{"issue":"3","key":"3840_CR18","first-page":"85","volume":"102","author":"R Capocasale","year":"1987","unstructured":"Capocasale R, Rispoli F, Frontespezi S (1987) Flupirtine: a double blind study with placebo on its analgesic activity in surgical pain. Riforma Medica 102(3):85\u201391","journal-title":"Riforma Medica"},{"key":"3840_CR19","doi-asserted-by":"crossref","unstructured":"Cherry C, Brew B, Downs C, Gregorio-King C, Cooke I, Rennie G, Goodchild C (2010) Flupirtine as an adjunct to OPIOID analgesia in HIV neuropathy pain. Eur J Pain Suppl.(1):78","DOI":"10.1016\/S1754-3207(10)70275-3"},{"key":"3840_CR20","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.2147\/JPR.S144647","volume":"10","author":"S Chinnaiyan","year":"2017","unstructured":"Chinnaiyan S, Sarala N, Arun HS (2017) A comparative study of efficacy and safety of flupirtine versus piroxicam in postoperative pain in patients undergoing lower limb surgery. J Pain Res 10:2471\u20132477","journal-title":"J Pain Res"},{"key":"3840_CR21","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3389\/fneur.2018.00842","volume":"9","author":"J D\u00f6rr","year":"2018","unstructured":"D\u00f6rr J, Wernecke KD, W\u00fcrfel J, Bellmann-Strobl J, Siffrin V, S\u00e4ttler MB, Simons M, Linsa A, Tumani H, Paul F (2018) Disease modification in multiple sclerosis by flupirtine-results of a randomized placebo controlled phase II trial. Front Neurol 9:842","journal-title":"Front Neurol"},{"issue":"1","key":"3840_CR22","first-page":"63","volume":"3","author":"C Fantini","year":"1986","unstructured":"Fantini C, Ciampini M, Silvij S (1986) Studio clinico verso placebo di un nuovo analgesico, la flupirtina, in traumatologia dello sport. Therapeutika 3(1):63\u201367","journal-title":"Therapeutika"},{"key":"3840_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1479-5876-11-34","volume":"11","author":"J Fleckenstein","year":"2013","unstructured":"Fleckenstein J, Sittl R, Averbeck B, Lang PM, Irnich D, Carr RW (2013) Activation of axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial. J Transl Med 11:34","journal-title":"J Transl Med"},{"issue":"9","key":"3840_CR24","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1185\/03007998509109640","volume":"9","author":"CS Galasko","year":"1985","unstructured":"Galasko CS, Courtenay PM, Jane M, Stamp TC (1985) Trial of oral flupirtine maleate in the treatment of pain after orthopaedic surgery. Curr Med Res Opin 9(9):594\u2013601","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"3840_CR25","first-page":"324","volume":"13","author":"H G\u00f6bel","year":"1999","unstructured":"G\u00f6bel H, Schmid J, Heinze A, Pergande G (1999) Reduction of spastic increased muscle tone in multiple sclerosis by the nonopioid analgesic flupirtine. Schmerz 13(5):324\u2013331","journal-title":"Schmerz"},{"issue":"2","key":"3840_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4103\/njms.NJMS_261_20","volume":"13","author":"AK Gupta","year":"2022","unstructured":"Gupta AK, Kohli M, Pandey PK, Dwivedi PD, Singh VP (2022) Comparative study of analgesia of ketorolac, tramadol, and flupirtine in the management of third molar surgery. Natl J Maxillofac Surg 13(2):262\u2013268","journal-title":"Natl J Maxillofac Surg"},{"issue":"4","key":"3840_CR27","first-page":"98","volume":"4","author":"R Jain","year":"2013","unstructured":"Jain R, Ratre BK (2013) Flupirtine reduces morphine requirements after carcinoma breast surgery: a randomized double blind controlled trial. Int J PharmSci 4(4):98\u2013104","journal-title":"IntJ PharmSci"},{"issue":"3","key":"3840_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5455\/ijsm.inguinalhernia","volume":"2","author":"J Karan","year":"2016","unstructured":"Karan J, Karwasra RK, Godara R, Bansal AR, Tripura R (2016) A prospective randomized comparative evaluation of flupirtine and diclofenac sodium in post inguinal hernia surgery pain. Int J Surg Med 2(3):107\u2013110>","journal-title":"Int J Surg Med"},{"issue":"1","key":"3840_CR29","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S1569-9056(12)60044-X","volume":"11","author":"MI Kogan","year":"2012","unstructured":"Kogan MI, Belousov II (2012) Comparative, single-centre, randomized, placebo-controlled study of efficacy and safety of flupirtine and celecoxib in CPPS\/CP IIIB. Eur Urol 11(1):e45\u2013e45a","journal-title":"Eur Urol"},{"key":"3840_CR30","doi-asserted-by":"crossref","unstructured":"Li C, Ni J, Wang Z, Li M, Gasparic M, Terhaag B, Uberall MA (2008) Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial*. Curr Med Res Opin 24(12):3523\u20133530","DOI":"10.1185\/03007990802579769"},{"key":"3840_CR31","unstructured":"L\u00fcben V, M\u00fcller H, Lobisch M, W\u00f6rz R (1994) [Treatment of tumor pain with flupirtine. Results of a double-blind study versus tramadol]. Fortschr Med\u00a0 112(19):282\u2013286"},{"issue":"11","key":"3840_CR32","first-page":"580","volume":"46","author":"H Magnussen","year":"1992","unstructured":"Magnussen H, Scheidt-Mackes M (1992) The effect of flupirtine on respiratory drive in healthy probands and patients with various lung diseases. Pneumol 46(11):580\u2013586","journal-title":"Pneumol"},{"issue":"5","key":"3840_CR33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/030006058801600503","volume":"16","author":"P Mastronardi","year":"1988","unstructured":"Mastronardi P, D\u2019Onofrio M, Scanni E, Pinto M, Frontespezi S, Ceccarelli MG, Bianchi F, Mazzarella B (1988) Analgesic activity of flupirtine maleate: a controlled double-blind study with diclofenac sodium in orthopaedics. J Int Med Res 16(5):338\u2013348","journal-title":"J Int Med Res"},{"issue":"5","key":"3840_CR34","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1365-2125.2011.04138.x","volume":"73","author":"MC Michel","year":"2012","unstructured":"Michel MC, Radziszewski P, Falconer C, Marschall-Kehrel D, Blot K (2012) Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years. Br J Clin Pharmacol 73(5):821\u2013825","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3840_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1185\/03007998409109581","volume":"9","author":"R Million","year":"1984","unstructured":"Million R, Finlay BR, Whittington JR (1984) Clinical trial of flupirtine maleate in patients with migraine. Curr Med Res Opin 9(3):204\u2013212","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"3840_CR36","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/bja\/55.5.429","volume":"55","author":"RA Moore","year":"1983","unstructured":"Moore RA, Bullingham RE, Simpson S, O\u2019Sullivan G, Evans PJ, McQuay HJ, Lloyd JW (1983) Comparison of flupirtine maleate and dihydrocodeine in patients following surgery. Br J Anaesth 55(5):429\u2013432","journal-title":"Br J Anaesth"},{"issue":"4","key":"3840_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.22159\/ajpcr.2019.v12i4.31699","volume":"12","author":"VK Naguri","year":"2019","unstructured":"Naguri VK, Komaram RB, Sagar TV (2019) Efficacy and tolerability of flupirtine versus tramadol in the treatment of moderate chronic low back pain. Asian J Pharm Clin Res 12(4):84\u201387","journal-title":"Asian J Pharm Clin Res"},{"issue":"3","key":"3840_CR38","first-page":"158","volume":"110","author":"SM Naser","year":"2012","unstructured":"Naser SM, Sarkar N, Biswas A, Kamal F, Prakash R, Rahaman QM, Das AK (2012) Efficacy and safety of flupirtine maleate and tramadol hydrochloride in postoperative pain management\u2013a prospective randomised double blinded study. J Indian Med Assoc 110(3):158\u2013160","journal-title":"J Indian Med Assoc"},{"issue":"3","key":"3840_CR39","first-page":"7","volume":"17","author":"PK Ojha","year":"2018","unstructured":"Ojha PK, Chatterji R, Gubta A, Chatterji C, Maniyar F (2018) A comparative study of the post operative analgesic efficacy of flupirtine maleate and ibuprofen in patients undergoing diagnostic laparoscopy for gynaecological surgeries under general anaesthesia. J Dent Med Sci 17(3):7\u201310","journal-title":"J Dent Med Sci"},{"issue":"5","key":"3840_CR40","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1212\/01.WNL.0000113764.35026.EF","volume":"62","author":"M Otto","year":"2004","unstructured":"Otto M, Cepek L, Ratzka P, Doehlinger S, Boekhoff I, Wiltfang J, Irle E, Pergande G, Ellers-Lenz B, Windl O et al (2004) Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study. Neurology 62(5):714\u2013718","journal-title":"Neurology"},{"issue":"1\u20132","key":"3840_CR41","first-page":"29","volume":"104","author":"G Pacilio","year":"1989","unstructured":"Pacilio G, Pizza C, Vetrano A, Mastrantoni M, Ceccarelli G (1989) A double-blind study on the effect of flupirtine as compared to paracetamol in the cancer pain. Riforma Medica 104(1\u20132):29\u201332","journal-title":"Riforma Medica"},{"issue":"1","key":"3840_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/PL00009797","volume":"14","author":"R Pothmann","year":"2000","unstructured":"Pothmann R, Lobisch M (2000) Acute treatment of episodic childhood tension-type headache with flupirtine and paracetamol - a double-blind crossover-study. Schmerz 14(1):1\u20134","journal-title":"Schmerz"},{"issue":"Suppl 3","key":"3840_CR43","first-page":"67","volume":"63","author":"W Scheef","year":"1987","unstructured":"Scheef W (1987) Analgesic efficacy and safety of oral flupirtine in the treatment of cancer pain. Postgrad Med J 63 (Suppl 3):67\u201370","journal-title":"Postgrad Med J"},{"issue":"1","key":"3840_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/1658-354X.169477","volume":"10","author":"D Thapa","year":"2016","unstructured":"Thapa D, Ahuja V, Dass C, Gombar S, Huria A (2016) Effect of preoperative flupirtine on postoperative morphine sparing in patients undergoing total abdominal hysterectomy. Saudi J Anaesth 10(1):58\u201363","journal-title":"Saudi J Anaesth"},{"issue":"10","key":"3840_CR45","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1185\/03007995.2012.726216","volume":"28","author":"MA Uberall","year":"2012","unstructured":"Uberall MA, Mueller-Schwefe GH, Terhaag B (2012) Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study. Curr Med Res Opin 28(10):1617\u20131634","journal-title":"Curr Med Res Opin"},{"key":"3840_CR46","unstructured":"W\u00f6rz R, Bolten W, Heller B, Krainick JU, Pergande G (1996) [Flupirtine in comparison with chlormezanone in chronic musculoskeletal back pain. Results of a multicenter randomized double-blind study]. Fortschr Med\u00a0 114(35\u201336):500\u2013504"},{"issue":"2","key":"3840_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/0970-9185.155143","volume":"31","author":"G Yadav","year":"2015","unstructured":"Yadav G, Behera SS, Das SK, Jain G, Choupoo S, Raj J (2015) Role of flupirtine as a preemptive analgesic in patients undergoing laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol 31(2):169\u2013173","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"1","key":"3840_CR48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/ANA.0b013e31829a04ad","volume":"26","author":"G Yadav","year":"2014","unstructured":"Yadav G, Choupoo S, Das SK, Das SK, Behera SS, Khuba S, Mishra LD, Singh DK (2014) Evaluating the role of flupirtine for postcraniotomy pain and compare it with diclofenac sodium: a prospective, randomized, double blind, placebo-controlled study. J Neurosurg Anesthesiol 26(1):32\u201336","journal-title":"J Neurosurg Anesthesiol"},{"issue":"2","key":"3840_CR49","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4103\/1658-354X.203028","volume":"11","author":"G Yadav","year":"2017","unstructured":"Yadav G, Jain G, Singh M (2017) Role of flupirtine in reducing preoperative anxiety of patients undergoing craniotomy procedure. Saudi J Anaesth 11(2):158\u2013162","journal-title":"Saudi J Anaesth"},{"issue":"4","key":"3840_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/pds.1207","volume":"15","author":"L Goldkind","year":"2006","unstructured":"Goldkind L, Laine L (2006) A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience. Pharmacoepidemiol Drug Saf 15(4):213\u2013220","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"3840_CR51","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1345\/aph.18364","volume":"33","author":"JM Rabkin","year":"1999","unstructured":"Rabkin JM, Smith MJ, Orloff SL, Corless CL, Stenzel P, Olyaei AJ (1999) Fatal fulminant hepatitis associated with bromfenac use. Ann Pharmacother 33(9):945\u2013947","journal-title":"Ann Pharmacother"},{"issue":"8","key":"3840_CR52","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1111\/j.1572-0241.1999.01321.x","volume":"94","author":"EB Hunter","year":"1999","unstructured":"Hunter EB, Johnston PE, Tanner G, Pinson CW, Awad JA (1999) Bromfenac (Duract)-associated hepatic failure requiring liver transplantation. Am J Gastroenterol 94(8):2299\u20132301","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"3840_CR53","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/03007995.2019.1594743","volume":"35","author":"S Kaplan","year":"2019","unstructured":"Kaplan S, Ehlken B, Hamann X (2019) Drug utilization patterns of flupirtine following implementation of risk minimization measures in Germany. Curr Med Res Opin 35(8):1397\u20131403","journal-title":"Curr Med Res Opin"},{"key":"3840_CR54","unstructured":"VigiAccess. World Health Organization. Available at: https:\/\/www.vigiaccess.org\/. Accessed 19 Apr 2025"},{"key":"3840_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6904-1-3","volume":"1","author":"YK Loke","year":"2001","unstructured":"Loke YK, Derry S (2001) Reporting of adverse drug reactions in randomised controlled trials - a systematic survey. BMC Clin Pharmacol 1:3","journal-title":"BMC Clin Pharmacol"},{"issue":"1","key":"3840_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/87551225211051593","volume":"38","author":"TA Boyle","year":"2022","unstructured":"Boyle TA, Morrison B, Mahaffey T (2022) Media generation and pharmacy regulatory authority awareness. J Pharm Technol 38(1):39\u201345","journal-title":"J Pharm Technol"},{"issue":"2","key":"3840_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.drudis.2020.10.017","volume":"26","author":"V Starokozhko","year":"2021","unstructured":"Starokozhko V, Kallio M, Kumlin Howell \u00c5, M\u00e4kinen Salmi A, Andrew-Nielsen G, Goldammer M, Burggraf M, L\u00f6bker W, B\u00f6hmer A, Agricola E et al (2021) Strengthening regulatory science in academia: STARS, an EU initiative to bridge the translational gap. Drug Discov Today 26(2):283\u2013288","journal-title":"Drug Discov Today"},{"issue":"4","key":"3840_CR58","doi-asserted-by":"publisher","first-page":"481","DOI":"10.6002\/ect.2019.0297","volume":"18","author":"F Dondorf","year":"2020","unstructured":"Dondorf F, Croner RS, Tautenhahn HM, Felgendreff P, Ardelt M, Settmacher U, Rauchfuss F (2020) Liver transplant due to flupirtine-induced acute liver failure. Exp Clin Transplant 18(4):481\u2013484","journal-title":"Exp Clin Transplant"},{"issue":"3","key":"3840_CR59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4103\/ija.ija_599_22","volume":"67","author":"S Dey","year":"2023","unstructured":"Dey S, Maurya I, Lohiya A, Arora P, Abdulkader RS, Chanu SM (2023) Efficacy of flupirtine for postoperative pain: a systematic review and meta-analysis. Indian J Anaesth 67(3):247\u2013255","journal-title":"Indian J Anaesth"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03840-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-025-03840-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03840-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:02:27Z","timestamp":1749578547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-025-03840-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["3840"],"URL":"https:\/\/doi.org\/10.1007\/s00228-025-03840-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve any humans or animals. This study analysed publicly available scholarly articles. For analysis of data extracted from scholarly articles, there is no need to ask for approval of the study protocol from an ethics committee or an institutional review board (IRB).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable. This study did not include humans. This study analysed publicly available scholarly articles.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The views expressed in this article are the personal views of the\u00a0author(s) and may not be understood or quoted as being made on behalf of or reflecting the position of the regulatory\u00a0agency\/agencies or organisations with which the author(s) is\/are employed\/affiliated.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}